In this study, we demonstrated a significant difference in complement factors in the Classical pathway (C1q, C2, C4 and C4b), Lectin pathway (MBL) and Alternative pathway (C3, Factor B and Factor D) among patients with and without an AAA. This evidence concerns the gene C3 and triple-A syndrome.